Roberto Darienzo has been appointed to the newly created position of chief operating officer at Halo Pharmaceutical. Mr. Darienzo has more than 30 years of industrial experience, with 22 years in technical and international general management roles in the pharmaindustry. He has held positions at Sanofi-Aventis based in Germany, served as vice president Americas Region for Schering-Plough, and subsequently for Merck with responsibility for 13 sites in North and South America.
 
“Halo is growing very rapidly and our international expansion plans strongly support the need for this new position,” said Clive Bennett, Halo Pharmaceutical’s president and chief executive officer. “In this new role, Roberto will initially be focused on our existing Contract Pharmaceutical Development and Contract Commercial Manufacturing activities in Whippany NJ and Montreal Quebec. We are delighted to have someone of Roberto’s stature in the industry join Halo”